NASDAQ: MRKR
Marker Therapeutics Inc Stock Ownership - Who owns Marker Therapeutics?

Insider buying vs selling

Have Marker Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Steve ElmsDirector2024-12-2311,085$3.20
$35.47kBuy
New Enterprise Associates 16 LP10% Owner2024-12-23554,250$3.20
$1.77MBuy

1 of 1

MRKR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MRKR insiders and whales buy or sell their stock.

MRKR Shareholders

What type of owners hold Marker Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Joshua Makower82.81%10,714,285$10.23MInsider
Carmen Chang82.81%10,714,285$10.23MInsider
Ali Behbahani82.81%10,714,285$10.23MInsider
Scott D. Sandell82.81%10,714,285$10.23MInsider
Anthony A. Florence Jr.82.81%10,714,285$10.23MInsider
Mohamad Makhzoumi82.81%10,714,285$10.23MInsider
Forest Baskett82.81%10,714,285$10.23MInsider
Peter W. Sonsini82.81%10,714,285$10.23MInsider
Paul Edward Walker82.81%10,714,285$10.23MInsider
John Robert Wilson60.38%7,812,008$7.46MInsider

1 of 3

MRKR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MRKR2.40%97.60%Net Buying
IMNN19.70%80.30%Net BuyingNet Buying
PHIO0.16%99.84%Net BuyingNet Selling
VIVS0.73%99.27%
BRTX0.24%99.76%Net Selling

Marker Therapeutics Stock Ownership FAQ

Who owns Marker Therapeutics?

Marker Therapeutics (NASDAQ: MRKR) is owned by 26.18% institutional shareholders, 1,064.65% Marker Therapeutics insiders, and 0.00% retail investors. Joshua Makower is the largest individual Marker Therapeutics shareholder, owning 10.71M shares representing 82.81% of the company. Joshua Makower's Marker Therapeutics shares are currently valued at $10.14M.

If you're new to stock investing, here's how to buy Marker Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.